Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Ipsen

Pharma Exec To Plead Guilty In Insider Trading Case: Report

Dishant Gupta allegedly used his wife's brokerage account to make more than $262,000 in illegal profits.

International Business Times

3 A-Rated Pharma Stocks to Boost Your Bottom Line

The pharmaceutical industry is experiencing rapid growth thanks to healthcare demand, regulatory initiatives, and technological adoption in drug discovery and development. Hence, it could be wise to invest in pharma stocks Ipsen (IPSEY), Bristol-Myers (BMY), and Taro Pharmaceutical (TARO) to drive your bottom line. These stocks are rated A (Strong…

StockNews.com

Why CymaBay Morphed From Dollar Stock To Biotech Rocket

CymaBay is sprinting to the finish line with a treatment for a serious liver disease and CBAY stock is on a massive run.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Stock Market Gains Led By Tech Stocks As Earnings Season Begins; Retail Stocks Sag

Stock market gains as earnings season begins. Retail stocks dip on weak Lululemon, Macy's forecasts.

Investors Business Daily

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Why Epizyme Shares Are Soaring Today

Epizyme Inc (NASDAQ: EPZM) shares are trading higher Monday after the company announced it entered into a definitive agreement to be acquired by Ipsen.

Benzinga

Life sciences firm Ipsen creating 50 jobs at its North Wales operation

Ipsen is investing further at Wrexham with a new drug product manufacturing facility

Birmingham Post

Read news from The Economist, FT, and more,
with one subscription

4 Mid-Cap Pharmaceutical Stocks to Buy This Month

Despite supply chain disruptions and labor shortages, the pharma industry is well-positioned to continue growing due to the increasing medical needs of an aging population and advancements in treating chronic diseases. Therefore, amid current market volatility, we believe it could be wise to scoop up shares of quality mid-cap pharmaceutical…

StockNews.com

People

Thomas Smith

44 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

Taro Pharmaceutical Industries Ltd

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.